Epigallocatechin‐3‐gallate treatment reduces thermal hyperalgesia after spinal cord injury by down‐regulating RhoA expression in mice

Abstract

These findings suggest that at short time EGCG treatment reduces thermal hyperalgesia and gliosis via FASN and RhoA pathway, causing a decrease in cytokines in spinal cord.